In the BioHarmony Drug Report Database

"Preview" Icon

Etravirine

Intelence (etravirine) is a small molecule pharmaceutical. Etravirine was first approved as Intelence on 2008-01-18. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections.

 

Trade Name

 

Intelence
 

Common Name

 

etravirine
 

ChEMBL ID

 

CHEMBL308954
 

Indication

 

hiv infections
 

Drug Class

 

Antivirals: non-nucleoside reverse transcriptase inhibitors, not benzoxazinone derivatives

Image (chem structure or protein)

Etravirine structure rendering